发明名称 BENZENE COMPOUNDS DISUBSTITUTED WITH CYCLIC GROUPS AT THE 1- AND 2-POSITIONS
摘要 A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.
申请公布号 EP1698620(B1) 申请公布日期 2016.09.28
申请号 EP20040808145 申请日期 2004.12.24
申请人 EISAI R&D MANAGEMENT CO., LTD. 发明人 KAWAHARA, TETSUYA;KOTAKE, MAKOTO;YONEDA, NAOKI;HIROTA, SHINSUKE;OHKURO, MASAYOSHI
分类号 C07D207/06;A61K31/381;A61K31/382;A61K31/40;A61K31/407;A61K31/4418;A61K31/451;A61K31/452;A61K31/4525;A61K31/495;A61K31/496;A61K31/4965;A61K31/5375;A61K31/5377;A61K31/55;A61P1/00;A61P1/04;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P37/06;A61P37/08;A61P43/00;C07D207/12;C07D207/273;C07D207/325;C07D211/14;C07D211/16;C07D211/18;C07D211/38;C07D211/42;C07D211/46;C07D211/56;C07D211/58;C07D211/62;C07D211/70;C07D211/72;C07D213/36;C07D213/64;C07D213/75;C07D233/04;C07D241/18;C07D257/04;C07D261/08;C07D265/30;C07D265/32;C07D271/10;C07D277/28;C07D295/02;C07D295/03;C07D295/067;C07D295/073;C07D295/08;C07D295/088;C07D295/096;C07D295/12;C07D295/135;C07D295/14;C07D295/15;C07D295/155;C07D295/18;C07D295/205;C07D307/52;C07D309/04;C07D309/14;C07D333/20;C07D335/02;C07D405/12;C07D413/02;C07D413/12;C07D487/08 主分类号 C07D207/06
代理机构 代理人
主权项
地址
您可能感兴趣的专利